Mind the Gaps

Amy Killelea of the National Alliance of State and Territorial AIDS Directors (NASTAD) sees healthcare coverage gaps everywhere, and as director of NASTAD’s new...

The Price of War

Cost of treatment and prevention in the war on viral hepatitis was the overriding theme of the first World Hepatitis Summit, which drew more...

High Bar

Working in HIV cure research, developing potential HIV therapeutics and eradication strategies focused on ABOBEC3g, Dr. Harold Smith of the University of Rochester had...

Affairs of the Heart

It is well known that people with hepatitis C virus (HCV) are at risk for liver damage, but the results of two new studies...

VA’s Hep Crisis

The newest class of antiretroviral drugs has sparked a revolution in the treatment of hepatitis C, but for the Department of Veterans Affairs, this...

Process of Elimination

As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s...

Red State Blues

As A&U reported in the June issue, the rise in HIV and hepatitis C (HCV) diagnoses in Scott County, Indiana, has put the state...

Do One Thing

With new, game-changing hepatitis C meds available or in the pipeline, an emerging issue is how to find at-risk patients, get them screened and...

MSF Access Campaign

Without Borders A global campaign for providing low-cost HCV care rolls out by Larry Buhl Last year UNITAID funded two grants to increase access to new treatments...

Equal HCV Treatment Benefits

A press conference at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) offered two main takeaways: that the new generation of oral direct-acting antiviral agents (DAAs) are highly effective and safe, and...

LATEST POSTS

Storytelling & Hep B

Changing the Conversation A new storytelling campaign puts a human face on hep B by Larry Buhl Healthcare professionals agree that stigma around hepatitis is the biggest...

POZIAM: Hank Trout